Follow
Yi Fu
Yi Fu
Johns Hopkins University School of Medicine Neurology
Verified email at jh.edu
Title
Cited by
Cited by
Year
Tau pathology in Parkinson's disease
X Zhang, F Gao, D Wang, C Li, Y Fu, W He, J Zhang
Frontiers in neurology 9, 809, 2018
1752018
Mitophagy in Parkinson’s disease: pathogenic and therapeutic implications
F Gao, J Yang, D Wang, C Li, Y Fu, H Wang, W He, J Zhang
Frontiers in neurology 8, 527, 2017
922017
TSPO deficiency induces mitochondrial dysfunction, leading to hypoxia, angiogenesis, and a growth-promoting metabolic shift toward glycolysis in glioblastoma
Y Fu, D Wang, H Wang, M Cai, C Li, X Zhang, H Chen, Y Hu, X Zhang, ...
Neuro-oncology 22 (2), 240-252, 2020
702020
Porcine reproductive and respiratory syndrome virus induces interleukin-15 through the NF-κB signaling pathway
Y Fu, R Quan, H Zhang, J Hou, J Tang, W Feng
Journal of virology 86 (14), 7625-7636, 2012
602012
Global deletion of TSPO does not affect the viability and gene expression profile
H Wang, K Zhai, Y Xue, J Yang, Q Yang, Y Fu, Y Hu, F Liu, W Wang, L Cui, ...
PLoS One 11 (12), e0167307, 2016
472016
Induction of interleukin-10 is dependent on p38 mitogen-activated protein kinase pathway in macrophages infected with porcine reproductive and respiratory syndrome virus
J Hou, L Wang, R Quan, Y Fu, H Zhang, W Feng
Virology journal 9, 1-10, 2012
372012
ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant glioma
C Hu, K Wang, C Damon, Y Fu, T Ma, L Kratz, B Lal, M Ying, S Xia, ...
Neuro-oncology 24 (6), 888-900, 2022
232022
Mutant IDH1 promotes phagocytic function of microglia/macrophages in gliomas by downregulating ICAM1
D Ma, D Zhan, Y Fu, S Wei, B Lal, J Wang, Y Li, H Lopez-Bertoni, F Yalcin, ...
Cancer letters 517, 35-45, 2021
172021
EGFR activates a TAZ-driven oncogenic program in glioblastoma
M Gao, Y Fu, W Zhou, G Gui, B Lal, Y Li, S Xia, H Ji, CG Eberhart, ...
Cancer research 81 (13), 3580-3592, 2021
132021
Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells
Q Li, Y Feng, Y Xue, X Zhan, Y Fu, G Gui, W Zhou, JP Richard, A Taga, ...
Molecular neurodegeneration 17, 1-18, 2022
102022
Frondoside a inhibits an MYC-driven medulloblastoma model derived from human-induced pluripotent stem cells
Y Xue, Y Fu, F Zhao, G Gui, Y Li, S Rivero-Hinojosa, G Liu, Y Li, S Xia, ...
Molecular cancer therapeutics 20 (6), 1199-1209, 2021
102021
Targeting UDP-α-d-glucose 6-dehydrogenase alters the CNS tumor immune microenvironment and inhibits glioblastoma growth
D Zhan, F Yalcin, D Ma, Y Fu, S Wei, B Lal, Y Li, O Dzaye, J Laterra, ...
Genes & Diseases 9 (3), 717-730, 2022
62022
Monoallelic IDH1 R132H mutation mediates glioma cell response to anticancer therapies via induction of senescence
D Zhan, D Ma, S Wei, B Lal, Y Fu, C Eberhart, J Laterra, M Ying, Y Li, ...
Molecular Cancer Research 19 (11), 1878-1888, 2021
22021
Targeting UDP-a-D-glucose 6-dehydrogenase alters the CNS tumor immune microenvironment and inhibits glioblastoma growth
D Zhan, F Yalcin, D Ma, Y Fu, S Wei, B Lal, Y Li, O Dzaye, J Laterra, ...
2021
Identification of Potential Immunogenic Molecules During the Allogeneic Transplantation of Human Adipose-derived Mesenchymal Stem Cells
D Wang, Y Fu, J Fan, C Li, Y Xu, H Chen, Y Hu, H Cao, RC Zhao, W He, ...
2020
EGF signaling activates a TAZ-driven oncogenic program in glioblastoma
M Gao, Y Fu, L John, M Ying
Cancer Research 79 (13_Supplement), 2608-2608, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–16